Besides immunosuppressive T cell subsets and cytokines, also low doses of interferon (IFN)-γ, which is mainly produced by activated Th1 cells or CD8+ T cells, can increase the stemness of tumor cells in NSCLC (95). The gene discussed is CD8A; the disease is neoplasm.